Market News
Stay updated with the latest market trends, earnings, and economic indicators.

Trust MF’s Mihir Vora sees earnings driving markets, stays bullish on industrials and renewables
Mihir Vora, Chief Investment Officer at Trust Mutual Fund, remains overweight on the industrial theme, particularly renewables, capital goods, and manufacturing-linked investments supported by production-linked incentive (PLI) schemes.
Citi downgrades India to 'Underweight' amid earnings and geopolitical risks
Mumbai Citi has downgraded India to underweight, citing persistent macroeconomic and geopolitical challenges alongside weaker earnings projections. The brokerage anticipates an 11.7% upside for the Nifty, reaching 27,000. While acknowledging lighter market positioning, Citi's earnings forecasts for FY27-28 are still factoring in the Iran War's impact. Banks, telecom, defence, and pharma are favored sectors.
Wealthtech platform ZFunds launches India’s first AI assistant for new-age wealth managers
ZFunds has launched ZIVA, an AI-powered assistant aimed at helping mutual fund distributors and wealth managers streamline workflows, improve client engagement, and automate portfolio analysis. The platform, tested in a pilot phase, claims to significantly reduce workload while enhancing efficiency through data-driven insights and multilingual support.

Exclusive: We are building a full-scale investment solutions firm, says Jio BlackRock CEO | Q&A
Jio BlackRock Mutual Fund rapidly climbs to 29th among 52 fund houses, manages about Rs 18500 crore, plans GIFT City SIFs, ETFs and commodity focused ETFs in coming months
Laurus Labs Ltd soars 1.75%, Gains for third straight session
Laurus Labs Ltd is quoting at Rs 1227.6, up 1.75% on the day as on 12:49 IST on the NSE. The stock is up 108.49% in last one year as compared to a 0.68% gain in NIFTY and a 14.53% gain in the Nifty Pharma index.
Gland Pharma Ltd gains for third consecutive session
Gland Pharma Ltd is quoting at Rs 1913.1, up 2.27% on the day as on 12:49 IST on the NSE. The stock is up 34.16% in last one year as compared to a 0.68% spurt in NIFTY and a 14.53% spurt in the Nifty Pharma index.

BSE wants more participation and products, not just a bigger market share, says CEO
Sundararaman Ramamurthy believes India’s mutual fund penetration remains low relative to the country’s population, leaving significant room for growth as financial awareness and retail participation continue to rise.
J B Chemicals & Pharmaceuticals Ltd spurts 0.08%, gains for fifth straight session
J B Chemicals & Pharmaceuticals Ltd is quoting at Rs 2144.9, up 0.08% on the day as on 12:44 IST on the NSE. The stock is up 40.69% in last one year as compared to a 0.65% jump in NIFTY and a 14.52% jump in the Nifty Pharma.
Torrent Pharmaceuticals Ltd spurts 0.14%, up for five straight sessions
Torrent Pharmaceuticals Ltd is quoting at Rs 4369, up 0.14% on the day as on 12:44 IST on the NSE. The stock is up 39.09% in last one year as compared to a 0.65% gain in NIFTY and a 14.52% gain in the Nifty Pharma.
Biocon Ltd soars 1.16%, gains for fifth straight session
Biocon Ltd is quoting at Rs 386.7, up 1.16% on the day as on 12:44 IST on the NSE. The stock is up 17.22% in last one year as compared to a 0.65% jump in NIFTY and a 14.52% jump in the Nifty Pharma.
Mankind Pharma Ltd up for fifth session
Mankind Pharma Ltd is quoting at Rs 2439.2, up 2.69% on the day as on 12:44 IST on the NSE. The stock is up 1.29% in last one year as compared to a 0.65% spurt in NIFTY and a 14.52% spurt in the Nifty Pharma.

Exclusive | Jio BlackRock gets GIFT City nod; to launch commodity ETFs in 3 months, says Sid Swaminathan
Jio BlackRock Mutual Fund gets IFSCA nod to start GIFT City operations, eyes global access for Indian and foreign investors, plans commodity ETFs in gold and silver soon